PLX - BTBT SFT and BLRX among pre-market losers
2023-10-09 08:23:30 ET
More on InMode, Mirati Therapeutics, etc.
- InMode: Bullish Support Failed To Materialize
- InMode: Strong Net Cash Position Sets The Stage For Opportunistic Buybacks
- InMode: Be Greedy When Others Are Fearful
- Bristol-Myers Squibb to acquire Mirati Therapeutics for $4.8B
- As FDA mulls fate of Amgen drug, Sanofi could snap up rival Mirati
For further details see:
BTBT, SFT and BLRX among pre-market losers